Trial · NCT00360490
Adverse events78
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 78
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Abdominal pain | Gastrointestinal disorders | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 3 | 82 | |
| other | Abdominal pain | Gastrointestinal disorders | Medroxyprogesterone Acetate (MPA) | 2 | 83 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 3 | 82 | |
| other | Abdominal pain lower | Gastrointestinal disorders | Medroxyprogesterone Acetate (MPA) | 5 | 83 | |
| other | Flatulence | Gastrointestinal disorders | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 2 | 82 | |
| other | Flatulence | Gastrointestinal disorders | Medroxyprogesterone Acetate (MPA) | 0 | 83 | |
| other | Fatique | General disorders | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 4 | 82 | |
| other | Fatique | General disorders | Medroxyprogesterone Acetate (MPA) | 2 | 83 | |
| other | Irritability | General disorders | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 2 | 82 | |
| other | Irritability | General disorders | Medroxyprogesterone Acetate (MPA) | 0 | 83 | |
| other | Vaginitis bacterial | Infections and infestations | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 9 | 82 | |
| other | Vaginitis bacterial | Infections and infestations | Medroxyprogesterone Acetate (MPA) | 3 | 83 | |
| other | Urinary tract infection | Infections and infestations | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 6 | 82 | |
| other | Urinary tract infection | Infections and infestations | Medroxyprogesterone Acetate (MPA) | 3 | 83 | |
| other | Sinusitis | Infections and infestations | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 5 | 82 | |
| other | Sinusitis | Infections and infestations | Medroxyprogesterone Acetate (MPA) | 4 | 83 | |
| other | Upper respiratory tract infection | Infections and infestations | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 5 | 82 | |
| other | Upper respiratory tract infection | Infections and infestations | Medroxyprogesterone Acetate (MPA) | 1 | 83 | |
| other | Bronchitis | Infections and infestations | Levonorgestrel Intrauterine System (LNG IUS) 20µg Per 24 Hours | 2 | 82 | |
| other | Bronchitis | Infections and infestations | Medroxyprogesterone Acetate (MPA) | 1 | 83 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00360490/events